Regeneration of human kidneys in animal models would help combat the severe shortage of donors in transplantation therapy. Previously, we demonstrated by interspecific blastocyst complementation between mouse and rats, generation of pluripotent stem cell (PSC)-derived functional pancreas, in apancreatic Pdx1 mutant mice. We, however, were unable to obtain rat PSC-derived kidneys in anephric Sall1 mutant mice, likely due to the poor contribution of rat PSCs to the mouse metanephric mesenchyme, a nephron progenitor. Here, conversely, we show that mouse PSCs can efficiently differentiate into the metanephric mesenchyme in rat, allowing the generation of mouse PSC-derived kidney in anephric Sall1 mutant rat. Glomerular epithelium and renal tubules in the kidneys are entirely composed of mouse PSC-derived cells expressing key functional markers. Importantly, the ureter-bladder junction is normally formed. These data provide proof-of-principle for interspecific blastocyst complementation as a viable approach for kidney generation.
O rgan transplantation is among the most effective treatments to improve quality-of-life (QOL) in patients with end-stage renal disease (ESRD). However, a chronic shortage of donor kidneys leaves many patients with ESRD no choice, but to undergo continued dialysis treatment, associated with poor QOL, high medical costs and risk of complications. Currently in the USA, an estimated 95,000 patients are waiting for a kidney transplant, resulting in an 80% kidney demand over all other organs 1 . Generation of transplantable kidneys from pluripotent stem cells (PSCs), such as embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs), is an attractive solution to this problem. However, despite advances in ex vivo generation of renal compartments from PSCs 2-5 , generating three-dimensional (3D), functional, and size-matched kidneys from PSCs remains a significant challenge 6 .
Blastocyst complementation is an innovative and potentially promising approach 7 : when blastocysts harvested from mutant animals lacking specific organs, are injected with PSCs, the entire organ generates from the PSCs, in the relevant developmental niche of the resultant chimeras. For instance, use of apancreatic Pdx1 mut/mut mouse host blastocysts allows the generation of PSCderived pancreas by blastocyst complementation, in allogenic, as well as in an interspecific setting between mouse and rat 8, 9 . Furthermore, transplantation of islets from mouse PSC-derived pancreas generated in Pdx1 mut/mut rats successfully restored blood glucose levels in diabetic mice, demonstrating a proof-ofconcept for the use of PSC-derived organs for therapy 9 .
For kidney generation, the anephric Sall1 mut/mut model, devoid of functional kidneys, can provide a suitable developmental niche for PSC-derived cells. Kidney formation requires reciprocally inductive interactions between the metanephric mesenchyme, a nephron progenitor, and the ureteric bud. The metanephric mesenchyme further differentiates into the glomerular epithelia and renal tubules. Sall1, an essential gene expressed in the metanephric mesenchyme, is crucial for ureteric bud attraction toward the mesenchyme in mice 10, 11 . Thus, Sall1 mut/mut mice show an anephric phenotype due to failed signaling at E11.5 10 . Mouse PSCs injected into the Sall1 mut/mut mouse blastocysts, form exclusively PSC-derived metanephric mesenchyme which interacts with the ureteric bud, resulting in the generation of mouse-PSC-derived kidney 12 . In an interspecific setting, however, we previously reported that rat PSCs fail to form kidneys in Sall1 mut/mut mice 12 , despite developing chimeric renal tissues in wildtype mice 9 . This finding impedes testing the therapeutic potential of kidneys created in a xenogenic environment, as well as in addressing fundamental questions in biology such as size regulation of solid organs.
Here, we show, in an interspecific setting between mouse and rat, that unlike rat PSCs, mouse PSCs efficiently contribute to Sall1 positive metanephric mesenchyme. Therefore, we are able to successfully generate mouse kidneys in the Sall1 mut/mut rat model by interspecific blastocyst complementation.
Results

Contribution of PSCs to metanephric mesenchyme in chimeras.
We first attempted to understand the causes behind the failure of interspecific blastocyst complementation, for kidney generation, when rat PSCs were injected into Sall1 mut/mut mouse blastocysts. Since, during allogenic blastocyst complementation, wildtype PSC-derived cells could replace mutant cells in the metanephric mesenchyme 12 , we reasoned that a required level of PSC contribution to the metanephric mesenchyme, is essential for the successful generation of the PSC-derived kidney. The metanephric mesenchyme expressing Sall1 and Six2, another nephron progenitor marker in mice 13, 14 , initiates the ureteric bud interaction Fetal metanephric mesencyme in interspecific chimeras between mouse and rat. a Representative photomicrographs of contribution of ESCs (pseudocolored green) to Sall1-positive cells (red) at E11.5 in interspecific chimera by injection of rat ESCs into wildtype mouse blastocysts and at E13.5 in that of mouse ESCs into wildtype rat blastocysts. The dotted line indicates the metanephric mesenchyme. Chimeric mice were generated by microinjecting tdTomato-labeled rat ESCs, into mouse blastocysts. Chimeric rats were generated by microinjecting GFP-labeled mouse ESCs into rat blastocysts. mBL mouse blastocyst, rBL rat blastocyst, mESCs mouse embryonic stem cells, rESCs rat embryonic stem cells. Scale bar: 100 μm. b Quantification of the contribution of Sall1-positive cells in a. Horizontal bars represent the mean percentage. All data were obtained from 2 independent experiments. *p < 0.05 by two-tailed Student's t-test analysis. Source data are provided as a Source Data file at E11.5 in mouse and E13.5 in rat ( Supplementary Fig. 1 ). Thus, we investigated a contribution of donor PSCs to the metanephric mesenchyme after injection of rat ESCs into wildtype mouse blastocysts (R-> M) and mouse ESCs into wildtype rat blastocysts (M-> R) ( Fig. 1a ). Quantitative immunohistological analysis revealed that, in the Sall1 positive metanephric mesenchyme, the contribution of rat ESCs in R-> M was significantly lower than that of mouse ESCs in M-> R (3.9 vs. 38.0%) ( Fig. 1b) . Notably, in R-> M, the contribution of rat ESCs to Sall1-negative surrounding tissues including the ureteric bud was not as low as the metanephric mesenchyme ( Fig. 1a ). Indicating that, rat PSCs are less efficient in differentiating specifically into the metanephric mesenchyme compared to other tissues in the mouse. These data suggest that, as in the previous study 12 , the number of rat PSC-derived metanephric mesenchyme in Sall1 mut/mut mouse might not be sufficient to attract the ureteric bud for renal development.
Generation and characterization of Sall1 mut/mut rats. Since mouse PSCs efficiently contribute to metanephric mesenchyme in M-> R in contrast to rat PSCs in R-> M, we believed we could generate mouse PSC-derived kidney in anephric rats by interspecific blastocyst complementation. To provide the necessary developmental niche for a kidney in the rat, we first created a Sall1 mut/mut rat model. We microinjected clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 constructs into rat zygote pronuclei, to delete an approximately 4.9 kb region containing exon 2 and exon 3 of rat Sall1 gene, and generated heterozygous founder rats ( Fig. 2a , Supplementary  Fig. 2a -c). After intercrossing heterozygous mutant rats, wildtype (Sall1 +/+ ), heterozygotes (Sall1 +/mut ), and homozygous mutant (Sall1 mut/mut ) zygotes developed to embryonic day 21.5 (E21.5) fetuses in a Mendelian fashion. Notably, the Sall1 mut/mut F0 fetus (CRISPR #7), as well as all of the Sall1 mut/mut F2 fetuses from CRISPR #1 line intercross exhibited a kidney-deficient (anephric) phenotype (Fig. 2b ), similar to Sall1 mut/mut mice 10 . To visualize the expression of Sall1 in rats, we also generated Sall1-tdTomato knock-in rats by replacing the Sall1 gene with tdTomato via homologous recombination (HR)-based gene targeting in rat ES cells ( Supplementary Fig. 3a-d ). While Sall1 tdTomato/ tdTomato neonates exhibited an anephric phenotype like Sall1 mut/ mut rats, Sall1 +/tdTomato neonate kidneys uniformly expressed tdTomato ( Fig. 2c ). Hematoxylin and eosin staining revealed the presence of a rudimentary kidney and intact ureter without functional nephric units in Sall1 tdTomato/tdTomato rats, whereas normal kidney histology was observed in Sall1 +/tdTomato and Sall1 +/+ rats (Fig. 2d ). In addition to the renal parenchyma, the expression of tdTomato was also observed in the brain, uterus, and limbs in both Sall1 tdTomato/tdTomato and Sall1 +/tdTomato neonates ( Fig. 2e ), which corresponds to the Sall1 expression pattern in mice 10, 15 ARTICLE kidney development, as well as in its tissue-wide expression pattern. Importantly, the anephric Sall1 mut/mut (including Sal-l1 tdTomato/tdTomato ) rat model can now provide the necessary developmental niche to generate a kidney.
Generation of mouse kidney in rat. We then performed interspecific blastocyst complementation using Sall1 mut/mut rat blastocysts with green fluorescent protein (GFP)-labeled mouse ESCs to generate mouse kidney in the rat. We injected 252 blastocysts derived from the intercross of Sall1 +/mut or tdTomato (CRISPR#1, HR#4) with mouse ESCs and transferred them into pseudopregnant rat uteri. A total of 76 of 110 fetuses were identified as interspecific chimeras, assessed by GFP fluorescence in the perinatal skin at E20.5-21.5 and P0. Retrospective genotype analysis revealed that Sall1 +/+ , Sall1 +/mut , and Sall1 mut/mut chimeric rats had been born with a Mendelian ratio ( Table 1 ). The mouse ESCs contributed to various organs including skin, muscle, heart, thymus, and kidney, but contributed less to the pancreas, liver, and lung regardless of genotyping ( Fig. 3a ). Average chimerism in splenic lymphocytes was 3.0%, independent of genotype ( Fig. 3b ).
In the kidney, all of the Sall1 +/mut and Sall1 +/+ chimeric neonates had chimeric kidneys composed of both donor-and hostderived cells, remarkably, of the 18 Sall1 mut/mut chimeric neonates, 12 (67%) had a pair of kidneys uniformly expressing GFP, indicating successful generation of mouse-PSC derived kidneys in the rats (Fig. 3c ). The rest of the Sall1 mut/mut chimeric neonates without kidneys showed low levels of chimerism in lymphocytes (red squares in Fig. 3b ). Thus, as in the Sall1 mut/mut mouse complemented with rat PSCs, low levels of chimerism, likely correlate with failure to form PSC-derived kidneys. Furthermore, we successfully generated kidneys derived from allogenic rat ESCs ( Supplementary Fig. 4a -c), as well as xenogenic mouse iPSCs ( Supplementary Fig. 4d-f ), demonstrating the consistency of blastocyst complementation in kidney, regardless of the donor cell types. While mouse ESC-derived kidneys in Sall1 mut/mut rats at P0 were histologically normal ( Fig. 3d ), their size was smaller than normal neonatal and Sall1 +/mut and Sall1 +/+ chimeric rats, and were similar to that of mice kidneys (Fig. 3e ). Thus, we hypothesize that at least until birth, the size of the kidney might either be under the control of certain species-specific intrinsic factor(s), or reflect the extent of chimerism of donor PSCs. We next investigated whether the Sall1 mut/mut chimeric fetuses survived to adulthood. We injected 148 blastocysts derived from intercrossing Sall1 +/mut rats with mouse ESCs; 63 of 100 offspring were GFP-positive interspecific chimeras. Only 21 of the offspring survived for more than 8 weeks. Notably, all of the 21 rats that survived to adulthood were either Sall1 +/+ (n = 9) or Sall1 +/mut (n = 12), whereas none of the Sall1 mut/mut rats with mouse PSC-derived kidneys survived much longer after birth due to defects in milk suckling ( Supplementary  Fig. 5a ), this phenotype corresponds to Sall1 mut/mut mice with mouse-PSC-derived kidneys 10 .
Characterization of mouse PSC-derived kidney in rat. We performed immunohistology to validate correct expression of functional markers of renal components and to identify the origin of the cells in the mouse-ESC derived kidneys in Sall1 mut/mut rats, at P0. We distinguish each renal component based on the specific functional markers ( Supplementary Fig. 6a , Supplementary  Table 1 ). In Sall1 +/+ and Sall1 +/mut chimeric rat kidneys, all the renal components consisted of a mixture of mouse and ratderived cells ( Fig. 4a, Supplementary Fig. 6b ). In contrast, mouse PSC-derived kidneys in Sall1 mut/mut chimeric rats, were entirely composed of GFP-positive mouse ESCs-derived cells, including the Nephrin 16 -positive podocytes, the Aquaporin 1 17 -positive proximal tubule, descending limb of loop of Henle, and loop of Henle, and the Na + /K + ATPase α-1 18 strongly positive ascending limb of loop of Henle and distal tubule ( Fig. 4a ). Correct localizations of these markers (Nephrin at glomerular basement membrane; Aquaporin 1 at both apical and basolateral plasma membrane; Na + /K + ATPase α-1 at basolateral plasma membrane) were detected. Notably, these markers are strongly associated with the functioning of the nephron, suggesting mouse PSCs differentiate correctly into functional cells in the xenogenic environment. Additionally, from the histological analysis, we found the Bowman's capsular epithelial cells formed outside the podocytes were also entirely mouse ESC derived (arrowheads in Fig. 4a upper right) . On the other hand, the Calbindin-positive collecting ducts in the renal medulla, and CD31-positive capillary vessels of the glomeruli and cortical blood vessels consisted of both mouse and rat derived cells (Fig. 4b) . These results indicate that all the metanephric mesenchyme-derived cells impaired in Sall1 mut/mut rats originate from mouse PSCs, whereas the other compartments in the kidney comprise both mouse PSCs and Sall1 mut/mut rat blastocysts (Fig. 4c ). The number of glomeruli in kidney was similar between Sall1 mut/mut chimeric rats and control mice ( Supplementary Fig. 7a, c) , while the size of glomeruli was similar between Sall1 mut/mut chimeric rats and control rats ( Supplementary Fig. 7b ).
We next investigated whether mouse ESC-derived kidneys can form proper ureter and bladder connections. An intraurethral dye infusion proved patency between the ureter and the bladder in two of the four P0 Sall1 mut/mut chimeras harboring mouse PSCderived kidneys (Fig. 4d ), indicating the organ has the potential to excrete urine.
Finally, to check if the filtering system in the kidneys work, we measured blood urea nitrogen (BUN) and creatinine (CRE) in the serum of Sall1 mut/mut chimeric rats with mouse PSC-derived kidney, 10-14 h after birth. No significant difference compared with Sall1 +/+ and Sall1 +/mut chimeras, as well as Sall1 mut/mut rats lacking kidneys was observed ( Supplementary Fig. 5b ), possibly due to inadequate activity of the neonates postnatally.
Discussion
Our work demonstrates the successful generation of mouse PSCderived kidneys in Sall1 mut/mut rats, by interspecific blastocyst complementation. This approach has succeeded for pancreas 8, 9 and thymus 19 generation between mouse and rats. However, applying interspecific blastocyst complementation for kidney genesis would have a more substantial impact on regenerative medicine, due to high donor demand in end-stage renal disease patients 20, 21 .
A key finding that we report is that sufficient contribution of xenogenic PSCs to the metanephric mesenchyme is essential for kidney formation. Histological analysis at the onset of metanephric mesenchyme and ureteric bud interaction revealed that contribution of rat PSCs to Sall1 positive metanephric mesenchyme in R-> M is less efficient than mouse PSCs in M-> R, which likely explains the failure of kidney formation in Sall1 mut/mut mice complemented with rat PSCs 12 . Also in M-> R, low chimerism of mouse PSCs is highly correlated with failure of complementation in Sall1 mut/mut rats. Thus, in the kidney, a minimum level of PSC contribution to the metanephric mesenchyme is required to initiate interaction with the ureteric bud. Since PSCs contribute to all other tissues to a similar extent in an allogenic setting, the interspecific variability for kidney formation is likely due to incompatibilities in environmental cues such as cytokines and extracellular matrix during development, rather than potency of the PSCs. As we have shown previously, in interspecific chimeras between mouse and rat, the level of contribution of the xenogenic PSCs varies from organ-to-organ 8, 22 . What factors specifically promote efficient PSC contribution ARTICLE remains unknown at this time. Nevertheless, the extent of contribution of xenogenic PSCs to the target organ, specifically the tissues or lineages to be replaced, should be an important consideration while choosing the appropriate host during interspecific blastocyst complementation.
The kidney generated by blastocyst complementation in our study is likely to function in vivo, based on expression of functional markers in the mouse PSC-derived nephron and the ureter-bladder junction. Additionally, we observed patency between ureter and bladder, which indicated normal development of the kidney, with potential to excrete urine. Although testing the filtering system in nephrons would strengthen evidence for its function, postnatal lethality of Sall1 mut/mut rat containing mouse PSC-derived kidney limits further investigation. Despite the presence of wildtype PSC-derived cells in chimeras, the milk suckling defect observed in Sall1 mut/mut rats was not rescued, akin to Sall1 mut/mut mouse with mouse PSC-derived kidney 12 . Sall1 is highly expressed in the olfactory bulb. Sall1 mutant olfactory bulbs are small in size, show abnormalities in neurogenesis and have reduced mitral cells, likely rendering the newborn mice anosmic and therefore unable to suckle milk 23, 24 . To overcome the limitations posed by the mutant host phenotype, disrupting other essential genes for kidney development should be examined. Alternately, conditionally deleting essential genes or ablating specific cells might be an avenue to explore.
For transplantation therapy, further elimination of host blastocysts derived cells would be essential to reduce the use of immunosuppressive treatment. While all the metanephric mesenchyme cells were of mouse PSC origin in Sall1 mut/mut rats, the ureteric bud-derived collecting tubes and blood vessels were composed of a mixture of donor and host cell types. Thus, a combination of genetically modified animals, which can provide the appropriate developmental niche, should be considered for complete replacement of the kidney by PSC-derived cells.
In the future, it might be possible to generate human PSCderived organs in livestock by using the blastocyst complementation approach. Despite successful contribution of human PSCs to pig embryos after blastocyst injection 25 , the chimerism was low and insufficient for organ development, like our observations for the kidney. Exploring alternative culture conditions of donor human PSCs or inhibition of apoptosis by forced expression of anti-apoptotic factors to prevent the elimination of PSC-derived cells might be helpful to increase chimerism [26] [27] [28] . Conversely, increasing interspecific chimerism associated with poor survival of the chimeras 8, 25 , and raises ethical concerns regarding the presence of human cells in neural or germline lineages 29 . Thus, limiting the potency towards a specific lineage by genetic manipulation in PSCs 30 , or contextdependent usage of differentiated cells from PSCs upon inhibiting apoptosis 26, 31 , may prove to be viable options to consider.
In conclusion, we have extended the application of interspecific blastocyst complementation between mouse and rat to generate fully developed kidneys. This study provides a tool to address fundamental questions on kidney ontogeny and regulation of size in solid organs and could offer clues to successful generation of human organs in animals.
Methods
Experimental statement. All procedures for animal experimentation were reviewed and approved by the Animal Care and Use Committee of the National Institute for Physiological Sciences. Specific pathogen-free Crlj:WI rats (RGD ID: 2312504) were purchased from Charles River Laboratories Japan, Inc. (Kanagawa, Japan). Specific pathogen-free C57BL/6 NCrSlc and C57BL/6N-Tg (CAG-EGFP) 32 mice were purchased from Japan SLC, Inc. (Shizuoka, Japan). All rats and mice were housed in an environmentally controlled room with a 12-h dark/12-h light cycle at 23 ± 2°C and humidity of 55 ± 5%, and given ad libitum access to a laboratory diet (CE-2; CLEA Japan, Inc., Tokyo, Japan) and filtered water. Study reagents were purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA) unless otherwise stated.
Generation of tdTomato-knockin rats at Sall1 locus. The targeting vector was constructed from a bacterial artificial chromosome (BAC) clone RNB1-261M04 33 using a counter-selection BAC modification kit and a BAC subcloning kit (Gene Bridges Gmbh, Heidelberg, Germany). The RNB1-261M04 was provided by RIKEN BRC through the National Bio-Resource Project of MEXT, Japan. In brief, tdTomato (Clontech, Mountain View, CA, USA) with FRT-PGK-gb2-neo-FRT cassette (Gene Bridges) was substituted at the site between the second and third exons located within functional DNA binding domains of the Sall1 gene (accession no. NM_001107415.2 (https://www.ncbi.nlm.nih.gov/ nuccore/NM_001107415.2)). The BAC backbone was replaced with a plasmid cassette containing a chloramphenicol resistance gene and ori from pACYC184 DNA (Nippon Gene Co., Ltd., Toyama, Japan). The final targeting vector was linearized by ScaI digestion.
Rat ESCs (WDB/Nips-ES1/Nips, RGD ID: 10054010) were cultured on mitomycin C (MMC)-treated Neo-MEFs (KBL9284100; Oriental Yeast Co., Ltd.
Tokyo, Japan) in 2iF medium consisting of N2B27 medium with 1-μM mitogenactivated kinase kinase (MEK) inhibitor PD0325901 (Stemgent Inc., Cambridge, MA, USA), 3-μM glycogen synthase kinase 3 (GSK3) inhibitor CHIR99021 (Axon Medchem, Groningen, The Netherlands), 1000 U/mL ESGRO ® (Merck Millipore, Burlington, MA, USA), and 10-μM forskolin. The targeting vector (25 μg) was introduced into 5 × 10 6 ESCs by electroporation at 800 V, 10 μF in 500 μL of N2B27 medium, and the electroporated ESCs were treated with 200-μg/mL G418 for 48 h. Knockin at the Sall1 locus was determined by PCR for tdTomato with AmpliTaq® DNA polymerase (Applied Biosystems Inc., Foster City, CA, USA) and for the 5'-upstream HR region of Sall1 locus with PrimeSTAR GXL DNA polymerase (Takara Bio Inc., Shiga, Japan), then confirmed by southern blot using DIG-labeled probes. E4.5 blastocysts were retrieved from Crlj:WI female rats, injected with recombinant ESCs using a piezo-driven micromanipulator (Prime Tech Ltd., Ibaraki, Japan), and transferred into uteri of pseudopregnant Crlj:WI females at 3.5 days post-coitum (dpc) to generate chimeric rats. F1 heterozygous offspring were derived from wildtype Crlj:WI females mated with male chimeras (. Genomic DNA samples were extracted from ear tissues, then used for PCR screening and genotyping in Sall1 locus. Primer sequences used for PCR screening, Southern blotting, and genotyping are listed in Supplementary Table 2 .
Generation of Sall1-knockout rats by CRISPR/Cas9 system. Pronuclear-stage zygotes were harvested from 7-8-week-old Crlj:WI females that had been superovulated by intraperitoneal injections of 150-IU kg −1 equine chorionic gonadotropin (eCG; Aska Pharmaceutical Co., Ltd., Tokyo, Japan) and human chorionic gonadotropin (hCG; Aska Pharmaceutical) at an interval of 48-50 h and had mated with fertile Crlj:WI males. Two guide sequences targeted at the second and third exons of rat Sall1 locus (target 1 and target 2: Fig. 2a ) were introduced into bicistronic expression vector px330 expressing Cas9 and single-guide RNA. The px330 vectors with one of the two guide sequences (2.5 ng μL −1 each) were coinjected into the pronucleus of zygotes. The zygotes were cultured for 16 h in mKRB medium at 37°C under 5% CO 2 in air, then evaluated for survival and cleavage to the 2-cell stage. All the surviving embryos were transferred into oviductal ampullae of pseudopregnant females at 0.5 dpc. Living fetuses were recovered from the recipient females at E21.5, or full-term offspring were delivered from the recipients. Genomic DNA was extracted from ear tissues of founder rats (#1-#12), and used for PCR screening and genotyping in Sall1 locus (Supplementary Table 2 ).
Generation of chimeras with PSCs. Mouse ESCs and iPSCs with GFP fluorescent marker (SGE2 12 and GT3.2 9 ), or rat ESCs with Venus fluorescent marker (Crlj:WI-ES1/Nips, RGD ID: 10053737) and tdTomato fluorescent marker (WDB-Rosa26 em1(RT2)Nips -ES2/Nips, RGD ID: 10054032) 34 , were used for blastocyst injection. For interspecific chimera generation, host blastocysts were obtained from Crlj:WI female rats (4.5 dpc) and C57BL/6NCrSlc female mice (3.5 dpc), respectively. For blastocyst complementation, heterozygous Sall1-KO females among HR#4 or CRISPR#1 rat lines were mated with heterozygous Sall1-KO males of the corresponding line, and the Sall1 +/mut × Sall1 +/mut rat blastocysts were retrieved at 4.5 dpc. Each of the seven PSCs that had been maintained on MMC-treated Neo-MEFs in the 2iF medium and isolated by trypsinization were microinjected into the blastocoel cavity of the blastocysts. Following a short-term recovery culture for 1-2 h, the injected blastocysts were transferred into uteri of pseudopregnant Crlj:WI females at 3.5 dpc (10-16 blastocysts per recipient). Fluorescence-based screening of chimeric rats was performed using E20.5-21.5 fetuses and P0 neonates, as well as genotype, chimerism and nephrogenetic phenotype analyses. Otherwise, the surrogate mothers were allowed to deliver, and the newborn offspring rats were analyzed for fluorescent marker expression, genotype, chimerism and phenotype either immediately or 8 weeks after birth.
Analysis of genotype and chimerism. Genomic DNA of chimeric rats was extracted from liver pieces or fluorescent-negative fraction of splenic lymphocytes sorted by fluorescence-activated cell sorting (FACS, SH800; Sony Corp., Tokyo, Japan). For HR#4 rat line, the Sall1 locus was amplified by PCR using F1, R1 and R2 primers (Supplementary Table 2 ). For CRISPR#1 rat line, the Sall1 locus was amplified by PCR using F1, R2 and R3 primers (Supplementary Table 2 ). Splenic lymphocytes were used to determine the fluorescence-based chimerism of each xenogeneic or allogeneic chimeric rat. The fluorescence-positive gates were set using the FACS histograms of the non-chimera samples (negative controls).
Histological analysis. Embryos and kidneys were fixed with 10% formalin neutral buffer solution or 4% paraformaldehyde and embedded in paraffin or in optimal cutting temperature (OCT) compound. Paraffin sections were deparaffinized with xylene, hydrated with graded ethanol, then HE-stained for light microscopy. Frozen sections with OCT compound were incubated with blocking buffer for 1 h at room temperature, and further incubated with primary antibody overnight at 4°C and secondary antibody for 1 h at room temperature. Primary antibodies used were anit-Sall1 polyclonal antibody (rabbit IgG, 1:100; ab31526, Abcam plc., Cambridge, UK) 35 , anit-Six2 polyclonal antibody (rabbit IgG, 1:100; 11562-1-AP, Proteintech Group, Inc., Rosemont, IL 60018, USA) 35 , anti-GFP polyclonal NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08394-9 ARTICLE
